-
Involving Women With Lived Experience of Pelvic Organ Prolapse in Designing and Refining the Economic Components of a Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Pulmonary Nodule (PN)-Related and Lung Cancer-Related Workup Costs Within the Two-Year Period After Diagnosis of a PN in the United States
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis Of Migalastat Incorporation vs. Enzyme Replacement Therapies For Fabry Disease: Validation of a Cost-Assessment Tool In Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Direct and Indirect Economic Burden Due to Chronic Limb-Threatening Ischemia (CLTI) in Germany
Sep 9, 2025, 16:22 PM -
A Contemporary Approach to Determining Cancer Patients Healthcare Resources Utilization
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of Ustekinumab Against Vedolizumab Among Inflammatory Bowel Disease Patients With Extra-intestinal Manifestations in Egypt
Sep 9, 2025, 16:22 PM -
Disparities in Access to Gene Therapy in the European Union: Ethical and Regulatory Challenges
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Belatacept as Conversion Therapy in the Management of Patients Living With a Renal Graft in France
Sep 9, 2025, 16:22 PM -
Adapting HTA Frameworks for Precision Medicine: Methodological Advances in the UK and EU4
Sep 9, 2025, 16:22 PM -
Evaluating GenAI vs. Human Screenshot Review Outputs in eCOA Localization: Does AI Hold the Key to Improved Feedback?
Sep 9, 2025, 16:22 PM -
Synthetic Data Generation Methods Using Artificial Intelligence (AI): A Simple New AI Tool That Generates Synthetic Data Using Generative Adversarial Network (CTGAN), Copula GANs, and Sequential Decision Tree Methods
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review to Identify Risk Factors and Symptoms of Long COVID-19 in Adult Indian Patients
Sep 9, 2025, 16:22 PM -
Social Determinants of Health Affecting Response to Opioid Addiction Treatment
Sep 9, 2025, 16:22 PM -
Artificial Intelligence-Powered Literature Reviews (AILRs): Streamlining Joint Clinical Assessment (JCA) Dossier Preparation for the Next Generation of Pharmaceutical Submissions
Sep 9, 2025, 16:22 PM -
Evaluating the Annual Cost of Progression in CD30+ Cutaneous T-cell Lymphomas Following 2L+ Systemic Treatment in Italy
Sep 9, 2025, 16:22 PM -
Shifts in the French HTA Transparency Committee’s Use of Indirect Comparisons: Insights From a Systematic Review of the French Transparency Committee (TC) Opinions
Sep 9, 2025, 16:22 PM -
Years of Life Lost and Productivity TB1 SY2 Costs Due to Premature Cancer-Related Mortality in Morocco
Sep 9, 2025, 16:22 PM -
Role of PROs in HTA and Reimbursement Decisions Across UK, Germany, France, Italy, and Spain
Sep 9, 2025, 16:22 PM -
Utility Values From Pooled Analysis of High Concentration (179 mg) Capsaicin Patch (HCCP) Studies In Peripheral Neuropathic Pain (PNP)
Sep 9, 2025, 16:22 PM -
Real-World Evidence in European Orphan Drug Submissions and the Impact on Reimbursement Success
Sep 9, 2025, 16:22 PM
